{"url":"https://newsforagent.com/news/2026-11-18/earkart-fda-establishment-registration-hearing-aids","markdown_url":"https://newsforagent.com/news/2026-11-18/earkart-fda-establishment-registration-hearing-aids.md","title":"earKART Completes FDA Registration for Four Hearing Aid Categories","headline":"earKART Completes U.S. FDA Establishment Registration and Secures Listings in Four Hearing Aid Categories","description":"earKART has completed U.S. FDA establishment registration and secured active listings across four hearing aid categories.","section":"Regulation & Approvals","published_at":"2026-11-18T13:02:16+00:00","modified_at":"2026-11-18T13:02:16+00:00","author":"News Desk","key_takeaways":["earKART completed U.S. FDA establishment registration and secured active medical device listings across four hearing aid categories.","The U.S. hearing aids market is projected to grow from $4.65 billion in 2026 to $9.57 billion by 2035, according to Emergen Research.","earKART reported annual revenue of Rs 43.11 crore and net profit of Rs 6.88 crore as of March 2025."],"companies":[{"name":"earKART","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0000cbw/earkart","website":"https://earkart.in"}],"source":{"publisher":"Ani News","title":"India's Earkart Limited Completes U.S. FDA Establishment Registration, Expands Global Hearing Healthcare Ambitions","url":"https://www.aninews.in/news/business/indias-earkart-limited-completes-us-fda-establishment-registration-expands-global-hearing-healthcare-ambitions20261118175310/"},"other_sources":[],"tags":["Regulation & Approvals","earKART"],"body_markdown":"earKART has completed U.S. Food and Drug Administration establishment registration and secured active medical device listings across four hearing aid categories, the company said on November 18, 2026. The Noida-based hearing healthcare technology company did not disclose financial terms for the registration. [ANI News](https://www.aninews.in/news/business/indias-earkart-limited-completes-us-fda-establishment-registration-expands-global-hearing-healthcare-ambitions20261118175310/) carried the announcement.\n\n## earKART's Four Hearing Aid Listings\n\n[earKART](https://akta.pro/company-profiles/0000cbw/earkart) is an India-based hearing healthcare technology company that develops, manufactures and distributes hearing aids and audiology equipment. The company's portfolio now covers Prescription Hearing Aids, Over-the-Counter (OTC) Hearing Aids, Wireless Prescription Hearing Aids and Wireless OTC Hearing Aids. The listings provide a foundation to explore opportunities across the U.S. hearing healthcare market, subject to applicable product-specific regulatory requirements.\n\nAccording to Emergen Research, the U.S. hearing aids market is estimated to grow from $4.65 billion in 2026 to $9.57 billion by 2035, at a CAGR of 8.4%. Global Market Insights projects the OTC hearing aids market to grow from $310.6 million in 2026 to $690.8 million by 2035.\n\nThe company said the development augments its Omni business potential and completes its hearing healthcare ecosystem, connecting scientific, full-stack diagnosis with remote hearing aid programming and the offering of earKART-branded hearing aids. earKART intends to offer its hearing aids to U.S. consumers at affordable prices, expanding access to hearing healthcare solutions.\n\nThe company said the milestone strengthens its international expansion ambitions, with plans to explore partnerships, distribution opportunities and market-entry strategies while leveraging its indigenous product development and manufacturing capabilities. \"Completing our U.S. FDA establishment registration and securing active device listings across four hearing aid categories is an important milestone in Earkart's international growth journey,\" the management of Earkart Limited stated. \"The United States offers significant opportunities for innovative and accessible hearing healthcare solutions.\"\n\n## earKART's Revenue and Government Order\n\nAccording to akta.pro [company records](https://akta.pro/company-data), earKART reported annual revenue of Rs 43.11 crore as of March 2025 and net profit of Rs 6.88 crore for the same period. The same records show a one-time BTE hearing aid supply order worth Rs 4.12 crore from ALIMCO via the Government e-Marketplace (GeM) platform in February 2026. The records also list a seed funding round in May 2023 led by Agility Ventures and an IPO completed in 2026 with a listing on BSE under BOM:544549.\n\n## What Comes Next for earKART\n\nThe company said it intends to leverage its product portfolio and manufacturing capabilities to explore strategic partnerships, distribution arrangements and appropriate market-entry strategies to build a sustainable international business. earKART's [own announcement](https://earkart.in) describes the registration as part of its international growth journey.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}